Crinetics Pharmaceuticals, Inc. reported that Jeff Knight resigned as Chief Development and Operating Officer effective April 10, 2026, and entered into a Consulting Agreement to provide services at $400 per hour, capped at 20 hours per month, from the same date until April 10, 2027.